Nano-inspired smart medicines targeting brain cancer: diagnosis and treatment
- 30 November 2022
- journal article
- review article
- Published by Springer Nature in JBIC Journal of Biological Inorganic Chemistry
- Vol. 28 (1) , 1-15
Abstract
Cancer, despite being the bull’s eye for the research community, accounts for a large number of morbidity and mortality. Cancer of the brain is considered the most intractable, with the least diagnosis rates, hence treatment and survival. Despite the extensive development of therapeutic molecules, their targeting to the diseased site is a challenge. Specially tailored nanoparticles can efficiently deliver drugs and genes to the brain to treat tumours and diseases. These nanotechnology-based strategies target the blood–brain barrier, the local space, or a specific cell type. These nanoparticles are preferred over other forms of targeted drug delivery due to the chances for controlled delivery of therapeutic cargo to the intended receptor. Targeted cancer therapy involves using specific receptor-blocking compounds that block the spreading or growth of cancerous cells. This review presents an account of the recent applications of nano-based cancer theragnostic, which deal in conjunct functionalities of nanoparticles for effective diagnosis and treatment of cancer. It commences with an introduction to tumours of the brain and their grades, followed by hurdles in its conventional diagnosis and treatment. The characteristic mechanism of nanoparticles for efficiently tracing brain tumour grade and delivery of therapeutic genes or drugs has been summarised. Nanocarriers like liposomes have been widely used and commercialized for human brain cancer treatment. However, nano-inspired structures await their translational recognition. The green synthesis of nanomaterials and their advantages have been discussed. The article highlights the challenges in the nano-modulation of brain cancer and its future outlook. Graphical AbstractKeywords
This publication has 101 references indexed in Scilit:
- Hydrothermally formed functional niobium oxide doped tungsten nanorodsNanotechnology, 2013
- Cyclic RGD-Linked Polymeric Micelles for Targeted Delivery of Platinum Anticancer Drugs to Glioblastoma through the Blood–Brain Tumor BarrierACS Nano, 2013
- Nanocomposite liposomes containing quantum dots and anticancer drugs for bioimaging and therapeutic delivery: a comparison of cationic, PEGylated and deformable liposomesNanotechnology, 2013
- Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case seriesJournal of Neuro-Oncology, 2012
- Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysisExperimental Hematology & Oncology, 2012
- Fabrication and growth mechanism of ZnO nanostructures and their cytotoxic effect on human brain tumor U87, cervical cancer HeLa, and normal HEK cellsJBIC Journal of Biological Inorganic Chemistry, 2010
- Antimicrobial Efficacy of Zinc Oxide Quantum Dots against Listeria monocytogenes, Salmonella Enteritidis, and Escherichia coli O157:H7Journal of Food Science, 2009
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Tumour-selective drug delivery via folate receptor-targeted liposomesExpert Opinion on Drug Delivery, 2004
- Effects of native defects on optical and electrical properties of ZnO prepared by pulsed laser depositionMaterials Science and Engineering: B, 2000